Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In an observational study, semaglutide was associated with a more than fourfold and sevenfold risk of nonarteritic anterior ischemic optic neuropathy in people taking semaglutide for type 2 diabetes and weight loss, respectively
Retatrutide progressed through early-phase clinical trials, showing strong potential for both glycemic control and weight reduction
Semaglutide, a medication for diabetes management and weight loss, mimics a hormone that regulates blood sugar and appetite but can also cause side effects, including dry mouth
It dramatically amplifies and accelerates the underlying disease process
US$ 27.23
US$ 28.22
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 26.42
US$ 27.78
US$ 24.98
